Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Its licence from the Medicines and Healthcare products Regulatory Agency (MHRA) is specifically for improving glycaemic control in adults with type 2 diabetes, either as monotherapy or in combination with other glucose-lowering medications
Baseline characteristics like age and BMI were similar between the two groups after researchers conducted matching
"Following the interim analysis, I would say we're confident in MariTide's differentiated profile, and believe it will address important unmet medical needs," Bradway said
Diabetologia 63 (10), 20572063
And the reason I ask, this is for practical reasons
US$ 28.55
US$ 28.15
US$ 20.92
US$ 20.30
US$ 27.49
US$ 20.20
